Superselective Intra-arterial Chemotherapy Treatment for Retinoblastoma- 5 Year Results From Turkey
NCT ID: NCT03935074
Last Updated: 2019-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2016-08-30
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The treatment outcomes, globe salvage rates and complications of superselective intra-arterial chemotherapy both for treating naive patients (primary treatment group) and for patients who received systemic chemotherapy previously (secondary treatment group) were evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intra-arterial Chemotherapy for Children With Retinoblastoma
NCT00906113
Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage
NCT01393769
Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome
NCT04681417
A Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma
NCT04455139
Quality of Life in Children Cured of Retinoblastoma
NCT00278031
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group 1
Patients who received intra-arterial chemotherapy as a first line treatment
intra-arterial administration of melphalan
group 2
Patients who received intra-arterial chemotherapy as a salvage treatment after systemic chemotherapy
intra-arterial administration of melphalan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intra-arterial administration of melphalan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* extraoculer involvement
* patients with blood dyscrasias, bleeding and clotting disorders
5 Months
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University - Cerrahpasa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bilge Batu Oto
Ophthalmology Specialist, Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul University Cerrahpasa School of Medicine Ophthalmology Department
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Saglam M, Sarici A, Anagnostakou V, Yildiz B, Kocer N, Islak C, Kizilkilic O. An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery. Neuroradiology. 2014 Sep;56(9):751-4. doi: 10.1007/s00234-014-1388-1. Epub 2014 Jun 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10136532
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.